Form 4 for IDXX Idexx Laboratories
Accepted 2023-09-08 00:00:00 ET · period of report 2023-09-06 · accession 0000874716-23-000123 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-08 | 2023-09-06 | IDXX | AYERS JONATHAN W | Dir | G - Gift | $0.00 | +147.8K | 281.9K | +110% | $0 | |
| I | 2023-09-08 | 2023-09-06 | IDXX | AYERS JONATHAN W | Dir | G - Gift | $0.00 | -147.8K | 302.2K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-06 | G | A | 147,821 | $0.00 | 281,868 | D | — | — | |
| 2 | Common | Common Stock | 2023-09-06 | G | D | 147,821 | $0.00 | 302,179 | I by Jonathan W. Ayers 2022 GRAT | — | — | (F1) The reporting person is the grantor and trustee of the Jonathan W. Ayers 2022 GRAT (the 'GRAT'). The GRAT is irrevocable, and the reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |